Novavax hands top execs $106M in stock options as COVID-19 vaccine nears the starting line
TrustVaccines
via FiercePharma: Vaccines https://ift.tt/2zKtXvv
April 30, 2021 at 12:44PM
Novavax hands top execs $106M in stock options as COVID-19 vaccine nears the starting line
Welcome to vaccine education 